Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $129.3400 (1.22%) ($127.1600 - $130.4900) on Fri. Apr. 5, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.42% (three month average) | RSI | 58 | Latest Price | $129.3400(1.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.6% a day on average for past five trading days. | Weekly Trend | LGND advances 0.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(55%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.71% in a week (0% probabilities). VXX(-15%) TLT(-15%) UUP(-10%) VIXM(-9%) IFRA(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.71% (StdDev 3.42%) | Hourly BBV | 0 () | Intraday Trend | 0.8% | | | |
|
5 Day Moving Average | $126.34(2.37%) | 10 Day Moving Average | $124.93(3.53%) | 20 Day Moving Average | $122.85(5.28%) | To recent high | -9.2% | To recent low | 22.1% | Market Cap | $2.079b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |